Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00895752Phase 4Completed
A Phase 4 trial of riluzole in Fragile X syndrome (FXS), sponsored by Indiana University. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00895752.